We should not be complacent about our population-based public health response to the first influenza pandemic of the 21st century

BMC Public Health

Volumn 11, Issue , 2011, Pages

  Kelly, Heath A ^a   Priest, Patricia C ^b   Mercer, Geoffry N ^c   Dowse, Gary K ^d  

^a VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c The Australian National University   (Australia)

^d DEPARTMENT OF HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

SIALIDASE;

ADOLESCENT; ARTICLE; AUSTRALIA; CHILD; DRUG EFFECT; HISTORY; HUMAN; INFLUENZA; INFLUENZA VIRUS A H1N1; ISOLATION AND PURIFICATION; MASS SCREENING; METHODOLOGY; ORGANIZATION AND MANAGEMENT; PANDEMIC; POLICY; PRESCHOOL CHILD; PUBLIC HEALTH; SCHOOL;

ADOLESCENT; AUSTRALIA; CHILD; CHILD, PRESCHOOL; HISTORY, 21ST CENTURY; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MASS SCREENING; NEURAMINIDASE; PANDEMICS; PUBLIC HEALTH; PUBLIC POLICY; SCHOOLS;

EID: 79551559919     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-11-78     Document Type: Review

References (58)

1. World now at the start of an influenza pandemic. M Chan, http://www.who.int/mediacentre/news/statements/2009/h1n1-pandemic-phase6- 20090611/en/index.html
2. UK response to H1N1 pandemic was highly satisfactory, independent review says. J Wise, BMJ 2010 341 3569 10.1136/bmj.c3569
3. The 2009 Influenza Pandemic. An independent review of the UK response to the 2009 influenza pandemic. D Hine Dame, London: Cabinet Office 2010
4. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. SA Webb V Pettila I Seppelt R Bellomo M Bailey DJ Cooper M Cretikos AR Davies S Finfer PW Harrigan, et al. N Engl J Med 2009 361 1925 1934 10.1056/NEJMoa0908481 19815860
5. Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome. A Davies D Jones M Bailey J Beca R Bellomo N Blackwell P Forrest D Gattas E Granger R Herkes, et al. JAMA 2009 302 1888 1895 10.1001/jama.2009.1535 19822628
6. A systematic review to inform institutional decisions about the use of extracorporeal membrane oxygenation during the H1N1 influenza pandemic. MD Mitchell ME Mikkelsen CA Umscheid I Lee BD Fuchs SD Halpern, Crit Care Med 2010 38 1398 1404 10.1097/CCM.0b013e3181de45db 20400902
7. Sub-optimal hand sanitiser usage in a hospital entrance during an influenza pandemic, New Zealand, August 2009. R Murray C Chandler Y Clarkson N Wilson M Baker R Cunningham, Euro Surveill 2009 14 19331 19761739
8. Pandemic (H1N1) 2009: Advice for the wearing of personal protective equipment for "frontline" staff. Queensland Government State Health Emergency Coordination Centre, http://newsletters.gpqld.com.au/content/Document/ H1N1/13%20August%2009/08%20CHOO27CMEAG-Frontline%20PPE%20- %2028%20July%2009%20Published.pdf
9. Australian Health Management Plan for Pandemic Influenza. Australian Government Department of Health and Ageing, http://www.flupandemic.gov.au/ internet/panflu/publishing.nsf/Content/ahmppi-2009
10. Australian Health Management Plan for Pandemic Influenza, Protect Phase Annex. Australian Government Department of Health and Ageing, http://www.flupandemic.gov.au/internet/panflu/publishing.nsf/Content/ protect-annex
11. Pandemic H1N1 influenza lessons from the southern hemisphere. M Baker H Kelly N Wilson, Euro Surveill 2009 14 19370 19883551
12. Protective effect of maritime quarantine in South Pacific jurisdictions, 1918-19 influenza pandemic. MA McLeod M Baker N Wilson H Kelly T Kiedrzynski JL Kool, Emerg Infect Dis 2008 14 468 470 10.3201/eid1403.070927 18325264 (Pubitemid 351451397)
13. Strategies for mitigating an influenza pandemic. NM Ferguson DA Cummings C Fraser JC Cajka PC Cooley DS Burke, Nature 2006 442 448 452 10.1038/nature04795 16642006 (Pubitemid 44264793)
14. Border screening for SARS in Australia: what has been learnt? G Samaan M Patel J Spencer L Roberts, Med J Aust 2004 180 220 223 14984341
15. Non-pharmaceutical interventions for pandemic influenza, national and community measures. DM Bell, Emerg Infect Dis 2006 12 88 94 16494723
16. The changing phases of pandemic (H1N1) 2009 in Queensland: an overview of public health actions and epidemiology. RD Appuhamy FH Beard HN Phung CE Selvey FA Birrell TH Culleton, Med J Aust 2010 192 94 97 20078411
17. Australia's winter with the 2009 pandemic influenza A (H1N1) virus. JF Bishop MP Murnane R Owen, N Engl J Med 2009 361 2591 2594 10.1056/NEJMp0910445 19940287
18. Community circulation of pandemic influenza H1N1 was established in one Australian state at the same time the virus was first recognised in North America. H Kelly GN Mercer JE Fielding GK Dowse K Glass D Carcione KA Grant PV Effler RA Lester, PLoS One 2010 5 11341 10.1371/journal.pone.0011341 20596536
19. Clinical diagnostic criteria for isolating patients admitted to hospital with suspected pandemic influenza. J Gerrard G Keijzers P Zhang C Vossen D Macbeth, Lancet 2009 374 1673 10.1016/S0140-6736(09)61983-8 19914506
20. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. E Miller K Hoschler P Hardelid E Stanford N Andrews M Zambon, Lancet 2010 375 1100 1108 10.1016/S0140-6736(09)62126-7 20096450
21. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. F Carrat E Vergu NM Ferguson M Lemaitre S Cauchemez S Leach AJ Valleron, Am J Epidemiol 2008 167 775 785 10.1093/aje/kwm375 18230677 (Pubitemid 351451744)
22. Viral shedding and clinical illness in naturally acquired influenza virus infections. LL Lau BJ Cowling VJ Fang KH Chan EH Lau M Lipsitch CK Cheng PM Houck TM Uyeki JS Peiris GM Leung, J Infect Dis 2010 201 1509 1516 10.1086/652241 20377412
23. Screening for influenza infection in international airline travelers. AR Duncan PC Priest LC Jennings CR Brunton MG Baker, Am J Public Health 2009 99 Suppl 2 360 362 10.2105/AJPH.2008.158071 19797749
24. Cutaneous infrared thermometry for detecting febrile patients. P Hausfater Y Zhao S Defrenne P Bonnet B Riou, Emerging Infectious Diseases 2008 14 1255 1258 10.3201/eid1408.080059 18680649
25. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. B Cao XW Li Y Mao J Wang HZ Lu YS Chen ZA Liang L Liang SJ Zhang B Zhang, et al. N Engl J Med 2009 361 2507 2517 10.1056/NEJMoa0906612 20007555
26. A biological model for influenza transmission: pandemic planning implications of asymptomatic infection and immunity. JD Mathews CT McCaw J McVernon ES McBryde JM McCaw, PLoS One 2007 2 1220 10.1371/journal.pone.0001220 18043733
27. Entry screening to delay local transmission of 2009 pandemic influenza A (H1N1). BJ Cowling LL Lau P Wu HW Wong VJ Fang S Riley H Nishiura, BMC Infect Dis 2010 10 82 10.1186/1471-2334-10-82 20353566
28. Policy statement - Prevention of influenza: recommendations for influenza immunization of children, 2007-2008. Committee on Infectious Diseases, Pediatrics 2008 121 1016 e1031 10.1542/peds.2008-0160 18381500
29. A small community model for the transmission of infectious diseases: comparison of school closure as an intervention in individual-based models of an influenza pandemic. GJ Milne JK Kelso HA Kelly ST Huband J McVernon, PLoS One 2008 3 4005 10.1371/journal.pone.0004005 19104659
30. Estimating the impact of school closure on influenza transmission from Sentinel data. S Cauchemez AJ Valleron PY Boelle A Flahault NM Ferguson, Nature 2008 452 750 754 10.1038/nature06732 18401408 (Pubitemid 351521077)
31. Progression and impact of the first winter wave of the 2009 pandemic H1N1 influenza in New South Wales, Australia. New South Wales public health network, Euro Surveill 2009 14 42 ii=19365
32. Pandemic H1N1 influenza surveillance in Victoria, Australia, April - September, 2009. J Fielding N Higgins J Gregory K Grant M Catton I Bergeri R Lester H Kelly, Euro Surveill 2009 14 19368 19883545
33. Influenza A (H1N1) in Victoria, Australia: a community case series and analysis of household transmission. C Looker K Carville K Grant H Kelly, PLoS One 2010 5 13702 10.1371/journal.pone.0013702 21060887
34. Household responses to pandemic (H1N1) 2009-related school closures, Perth, Western Australia. PV Effler D Carcione C Giele GK Dowse L Goggin DB Mak, Emerg Infect Dis 2010 16 205 211 20113548
35. Pros and cons of estimating the reproduction number from early epidemic growth rate of influenza A (H1N1). H Nishiura G Chowell M Safan C Castillo-Chavez, Theor Biol Med Model 2009 7 1 10.1186/1742-4682-7-1
36. School closure and mitigation of pandemic (H1N1) 2009, Hong Kong. JT Wu BJ Cowling EH Lau DK Ip LM Ho T Tsang SK Chuang PY Leung SV Lo SH Liu S Riley, Emerg Infect Dis 2010 16 538 541 10.3201/eid1603.091216 20202441
37. Closure of schools during an influenza pandemic. S Cauchemez NM Ferguson C Wachtel A Tegnell G Saour B Duncan A Nicoll, Lancet Infect Dis 2009 9 473 481 10.1016/S1473-3099(09)70176-8 19628172
38. Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis. T Jefferson M Jones P Doshi C Del Mar, BMJ 2009 339 5106 10.1136/bmj.b5106 19995812
39. Swine flu drug hand-out service raises concern. N Triggle, http://news.bbc.co.uk/2/hi/health/10491328.stm
40. Oseltamivir ring prophylaxis for containment of 2009 H1N1 influenza outbreaks. VJ Lee J Yap AR Cook MI Chen JK Tay BH Tan JP Loh SW Chew WH Koh R Lin, et al. N Engl J Med 2010 362 2166 2174 10.1056/NEJMoa0908482 20558367
41. Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa. AC Hurt J Ernest YM Deng P Iannello TG Besselaar C Birch P Buchy M Chittaganpitch SC Chiu D Dwyer, et al. Antiviral Res 2009 83 90 93 10.1016/j.antiviral.2009.03.003 19501261
42. Weekly update on oseltamivir resistance to pandemic influenza A (H1N1) 2009 viruses. World Health Organization, http://www.who.int/entity/csr/disease/ influenza/2011-01-28-weekly-web-update-oseltamivir-resistance.pdf
43. Mortality of 2009 pandemic influenza A(H1N1) in Germany. H Wilking S Buda E von der Lippe D Altmann G Krause T Eckmanns W Haas, Euro Surveill 2010 15 49 ii=19741 21163179
44. Free Pandemic Flu Vaccine Available For All. Australian Government Department of Health and Ageing, http://www.health.gov.au/internet/ministers/ publishing.nsf/Content/907DAC8DDA4756C6CA25764100112643/$File/nr167.pdf
45. 2010 Pandemic Vaccination Survey: Summary results. Australian Government Australian Institute of Health and Welfare, Cat no PHE 128 2010
46. An audit of pandemic (H1N1) 2009 influenza vaccine wastage in general practice. CE Turnour SJ Conaty MA Cretikos, Med J Aust 2010 192 541 20438435
47. Single-dose versus multi-dose vaccine vials for immunization programmes in developing countries. PK Drain CM Nelson JS Lloyd, Bull World Health Organ 2003 81 726 731 14758432 (Pubitemid 37429072)
48. Pandemic (H1N1) 2009 influenza vaccination coverage in Western Australia. DB Mak AM Daly PK Armstrong PV Effler, Med J Aust 2010 193 401 404 20919971
49. Influenza vaccine - safe, effective, and mistrusted. KM Harris J Maurer AL Kellermann, N Engl J Med 2010 363 2183 2185 10.1056/NEJMp1012333 21105831
50. Pandemic influenza A(H1N1) 2009 breakthrough infections and estimates of vaccine effectiveness in Germany 2009-2010. O Wichmann P Stocker G Poggensee D Altmann D Walter W Hellenbrand G Krause T Eckmanns, Euro Surveill 2010 15 18 ii=19561 20460094
51. Protective effect of single-dose adjuvanted pandemic influenza vaccine in children. PG Van Buynder JK Dhaliwal JL Van Buynder C Couturier M Minville-Leblanc R Garceau FW Tremblay, Influenza Other Respi Viruses 2010 4 171 178 10.1111/j.1750-2659.2010.00146.x 20629771
52. Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: Results of influenza monitoring vaccine effectiveness in Europe (I-MOVE) multicentre case-control study. M Valenciano E Kissling JM Cohen B Oroszi B A C Rizzo B Nunes D Pitigoi LC Amparro A Mosnier, et al. Plos Med 2010 9 1 1000388 10.1371/journal.pmed.1000388
53. Pandemic severity index. Centers for Disease Control and Prevention, http://www.flu.gov/professional/community/commitigation.html#XVI
54. Studies needed to address public health challenges of the 2009 H1N1 influenza pandemic: Insights from modeling. MD Van Kerkhove T Asikainen NG Becker S Bjorge JC Desenclos T dos Santos C Fraser GM Leung M Lipsitch IM Longini Jr, et al. PLoS Med 2010 7 1000275 10.1371/journal.pmed.1000275 20532237
55. Conflicts of interest and pandemic flu. F Godlee, BMJ 2010 340 2947 10.1136/bmj.c2947 20525680
56. Influenza A/H1N1-09: Australia and New Zealand's winter of discontent. T Kotsimbos G Waterer C Jenkins PM Kelly A Cheng RJ Hancox M Holmes R Wood-Baker S Bowler L Irving P Thompson, Am J Respir Crit Care Med 2010 181 300 306 10.1164/rccm.200912-1878CP 20130145
57. Pandemic influenza: severity must be taken into account. P Doshi, J Infect Dis 2010 201 1444 1445 10.1086/651701 20367441
58. Challenges of pandemic influenza nationally and internationally. S Briand, http://www.hpa-events.org.uk/hpa/frontend/reg/titem.csp?pageID= 51531&eventID=110&eventID=11